True ROI for R&D won't come from the tool that generates 10,000 new ideas. It will come from the tool that confidently tells ...
Dr Yves R. Sagaert emphasizes the importance of organizations shifting away from traditional static budgeting, which relies ...
Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...
Artificial intelligence is redefining how fire tests are used in polyurethane foam R&D, delivering faster insights and ...
Kumho Tire has partnered with Ansible Motion to develop next-generation digital tires. The two companies will use advanced ...
The Consumer Electronics Show in Las Vegas drew hundreds of thousands from the tech industry this week to preview the year ...
4d
A person claiming to be a food delivery company 'whistleblower' fooled the internet with AI's help
An anonymous Reddit user’s claims of fraud and theft by an unnamed food delivery company appear to have been an artificial ...
BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...
13don MSN
Biology-inspired brain model matches animal learning and reveals overlooked neuron activity
A new computational model of the brain based closely on its biology and physiology has not only learned a simple visual ...
Thermal processing technology has come a long way, but food & beverage processors still seek more consistency, stability and ...
TEL AVIV, Israel, Jan. 9, 2026 /PRNewswire/ -- CytoReason, a leader in AI-powered computational disease modeling, today announced the expansion of its collaboration with Sanofi for the third time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback